bioAffinity Technologies, Inc. Repayments of Bank Debt
bioAffinity Technologies, Inc. (BIAF) reported Repayments of Bank Debt of $251.75 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfBankDebt · last filed 2023-11-14
- bioAffinity Technologies, Inc. repayments of bank debt for the quarter ending 2023-09-30 was $42.33K.
- bioAffinity Technologies, Inc. repayments of bank debt for the quarter ending 2023-06-30 was $126.10K.
- bioAffinity Technologies, Inc. repayments of bank debt for the quarter ending 2023-03-31 was $83.32K.
- bioAffinity Technologies, Inc. repayments of bank debt for the quarter ending 2022-12-31 was $238.37K.
- bioAffinity Technologies, Inc. repayments of bank debt for fiscal 2022 was $269.98K.
| Period end | Repayments of Bank Debt 3 month | Repayments of Bank Debt 6 month | Repayments of Bank Debt 9 month | Repayments of Bank Debt 12 month |
|---|---|---|---|---|
| 2023-09-30 | $42.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $168.43K derived: sum of 2 quarters · filed 2023-11-14 | $251.75K 10-Q · filed 2023-11-14 | $490.12K derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $126.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $209.41K 10-Q · filed 2023-08-14 | $447.78K derived: sum of 3 quarters · filed 2023-08-14 | |
| 2023-03-31 | $83.32K 10-Q · filed 2023-05-15 | $321.69K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2022-12-31 | $238.37K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $269.98K 10-K · filed 2023-03-31 | ||
| 2022-09-30 | $31.61K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |